Metodologia de desenvolvimento e validação de kit imunocromatográfico adotando como modelo o teste rápido para detecção do hormônio luteinizante (LH)

Detalhes bibliográficos
Ano de defesa: 2015
Autor(a) principal: Camargo, Maria Angélica de
Orientador(a): Thiemann, Otávio Henrique lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de São Carlos
Câmpus São Carlos
Programa de Pós-Graduação: Programa de Pós-Graduação em Genética Evolutiva e Biologia Molecular - PPGGEv
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: https://repositorio.ufscar.br/handle/20.500.14289/8130
Resumo: Despite the rapid tests market in Brazil being in full expansion, the country does not have a tradition of manufacturing these kits. Therefore, it is very difficult to find, in the national literature, reports to guide the development process of these kits. The lack of published reports is aggravated by the difficulty of understanding the rules and laws governing the sector and by their subjectivity. The aim of this study was to describe a methodology to develop and validate a diagnostic kit, according to prevailing regulations. For this, a self-diagnostic semiquantitative kit for detection of Luteinizing Hormone (LH), using the rapid test platform, was taken as a model and all the procedures required in each stage of the design of the product, including planning, development and validation, have been described. The kit developed complied with all established operating requirements and achieved 97.39% sensitivity and 97.92% specificity. The cross-reaction tests showed that the kit suffers interference from samples containing hCG, due to the high similarity of beta chains of the hormones. Despite this fact, the performance of the test was better than the performance of the kit available in the market today. Based on the results obtained, we conclude that the procedures presented, which comply with the management standards ISO 9001:2008 and ISO 13485:2004 and also with the Good Manufacturing Practices of the RDC 16/2013, were effective in obtaining the kit and may be used as a model for management and development of similar projects within companies operating in the diagnostic market.